Phase 4 N=100 Airway Responses During Desflurane Anesthesia Via a Laryngeal Mask Airway: Effects of Fentanyl Pretreatment
Administration Site Reaction
Primary: Movement — 8; 24 Participants, number
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=40 Prospective Study of Efficacy of Intra-muscular Vitamin D3 in Tropical Calcific Pancreatitis
Pancreatitis, Chronic
Primary: Percentage of Patients With Serum 25 Hydroxy Vitamin D3 > 30 ng/ml — 85; 29; 0 percentage of patients
Phase 4 N=81 Continuous Levalbuterol for Treatment of Status Asthmaticus in Children
Asthma
Primary: Duration of Continuous Therapy — 18.3; 16 Hours
Phase 4 N=56 Effectiveness of Sertraline and Cognitive Behavioral Therapy in Treating Pediatric Obsessive-Compulsive Disorder
Obsessive-Compulsive Disorder
Primary: Clinical Global Impression - Severity of Activation (CGI-SA) — .50; 2.00; 2.00 units on a scale — p=.2106
Phase 4 N=990 A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.
Urinary Bladder, Overactive
Primary: Mean Number of Urgency Urinary Incontinence (UUI) Episodes Per 24 Hours — 3.93; 1.60 episodes per 24 hours — p=<0.0001
Phase 4 N=150 Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis
Psoriasis
Primary: Percentage of Participants With Psoriasis Area and Severity Index (PASI)-75 Response at Week 4 — 31 percentage of participants
Phase 4 N=43 BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.
HIV
Primary: Maintenance of Virologic Suppression — 13; 14; 10; 0 participants
Phase 4 N=178 100% VS 80% Of Pegasys In Koreans With Chronic Hepatitis C (CHC)
Sustained Virologic Response · IL28B Polymorphism
Primary: Sustained Virologic Response Depending on the Dosage of Peginterferon Alfa 2a — 52; 44 participants who achieved SVR
Phase 4 N=120 Usefulness of Lidocaine as Topical Pharyngeal Anaesthesia in Esophagogastroduodenoscopy Under Sedation With Propofol
Esophagogastroduodenoscopy
Primary: Rate of Administration of Propofol 1% Required to Obtain Uniform Sedation During Endoscopy — 310.7; 280.1 mcg/kg/min — p=<0.05
Phase 4 N=54 The Effects of Anti-Inflammatory Treatment on Insulin Resistance in Healthy Volunteers
Type 2 Diabetes · Diabetes
Primary: Change in Fasting Plasma Glucose Concentration — 4.7; 0.0 mmol/l
Phase 4 N=20 Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment
Schizophrenia
Primary: Change From Baseline in Insulin Sensitivity — 3.2; 0.4 microUnits/mL — p=0.08
Phase 4 N=170 Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis
Allergic Conjunctivitis
Primary: Mean Change From Baseline in Staff-Assessed Ocular Redness, Area Under the Curve From Time Zero to Hour 10 [AUC (0-10)], Maxidex and Placebo — 18.120; 19.362; 16.823…
Phase 4 N=40 Safety and Efficacy Study of Paliperidone Extended Release (ER) Among Thai Schizophrenia Participants
Schizophrenia
Primary: Change From Baseline in Clinical Global Impression Severity (CGI-S) Scale at Week 10 — 3.55; 0.82 Units on a scale — p=0.000
Phase 4 N=20 A Study Evaluating the Efficacy of Fluocinonide Cream 0.1% (Vanos) in Subjects With Atopic Dermatitis
Atopic Dermatitis
Primary: Change in Investigator Global Assessment of Atopic Dermatitis Severity From Baseline to Day 2/3. — -0.72 Scores on a scale
Phase 4 N=22 Compare Effect of Surgical Antiseptic Preparations on Incise Drape Adhesion to Skin
Healthy
Primary: Drape Adhesion — 78.6; 181.3 grams-force